JAY S SKYLER, MD
Osteopathic Medicine at 10 Ave, Miami, FL

License number
Florida ME29134
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
1450 NW 10Th Ave, Miami, FL 33136
Phone
(305) 243-3636
(305) 243-6575 (Fax)

Organization information

See more information about JAY S SKYLER at bizstanding.com

Jay S. Skyler, Inc

445 Grand Bay Dr, Miami, FL 33149

Status:
Inactive
Registration:
Dec 4, 2001
State ID:
P01000115393
Business type:
Domestic for Profit Corporation
Director:
Jay S. Skyler Director, inactive
Agent:
Marjorie E. Wolasky

Professional information

Jay S Skyler Photo 1

Dr. Jay S Skyler, Miami FL - MD (Doctor of Medicine)

Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
Kosow Diabetes Treatment Center
1450 NW 10Th Ave, Miami 33136
(305) 243-3636 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1973, Internal Medicine, 1972
Awards:
Healthgrades Honor Roll
Languages:
English, French, Spanish
Hospitals:
Kosow Diabetes Treatment Center
1450 NW 10Th Ave, Miami 33136
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
Education:
Medical School
Jefferson Medical College Of Thomas Jefferson University, Thomas Jefferson University
Graduated: 1969
Duke University Med Center
Graduated: 1970
Graduated: 1971
Graduated: 1973


Jay Samuel Skyler Photo 2

Jay Samuel Skyler, Miami FL

Specialties:
Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism, Otolaryngology
Work:
Miami Va Healthcare System
1201 NW 16Th St, Miami, FL 33125 University of Miami
1450 NW 10Th Ave, Miami, FL 33136
Education:
Thomas Jefferson University (1969) Internal Medicine


Jay Skyler Photo 3

Method And Composition For Treatment Of Insulin Resistance Syndromes

US Patent:
5422125, Jun 6, 1995
Filed:
Oct 12, 1994
Appl. No.:
8/322397
Inventors:
Jay S. Skyler - Key Biscayne FL
Phillip Frost - Miami Beach FL
Elliot F. Hahn - North Miami Beach FL
Assignee:
Baker Norton Pharmaceuticals, Inc. - Miami FL
International Classification:
A61K 3326, A61K 3726
US Classification:
424646
Abstract:
A method of treating human or animal patients suffering from insulin resistance syndromes, particularly diabetes mellitus, by administering an effective amount of the compound magnesium vanadate. Daily dosage ranges are preferably from about 2 to about 60 mg per kg of patient body weight. Pharmaceutical compositions for use in the method of treatment include magnesium vanadate and at least one pharmaceutically acceptable inert ingredient, and may be oral, parenteral, transdermal or transmucosal dosage forms containing from about 50 to about 1000 mg of magnesium vanadate per unit.